Photo of Peter Zhang

Peter Zhang Partner

Speaks:  English, Mandarin, Cantonese

Year of Call: 2018 - Ontario

Year of Call: 2008 - China

Primary phone: +1 416-814-5650

Fax: +1 416-862-7661

Email: peter.zhang@gowlingwlg.com

Download vCard

Primary office:  Toronto

Practice areas:

Connect via LinkedIn

Peter Zhang

Peter (Dongcheng) Zhang is a partner at Gowling WLG, where he leads the firm's China Initiative for the Toronto office.

Admitted to practise law in Ontario and China, Peter's main areas of expertise include corporate finance, mergers and acquisitions and foreign direct investment. He holds particular experience in assisting Chinese high net worth individual clients investing in Canada, and dealing with immigration, regulatory and various legal matters in Canada. Peter also advises clients in intellectual right protection, licensing, incorporating joint ventures in China.

Fluent in Mandarin, Cantonese and English, Peter spent 10 years working as an investment banker at tier one investment banking and research institutions in China. Prior to joining Gowling WLG, he was a partner at an international law firm based in Asia.

Practice areas

Career & Recognition

Filter timeline:

  • 2018

    • Qualifications (Year of Call/Admission, etc.)
      June 2018
      Year of Call, Ontario

  • 2017

    • Education
      September 2017
      University of Toronto, LLM

  • 2008

    • Qualifications (Year of Call/Admission, etc.)
       2008
      Year of Call, China

  • 1995

    • Education
       1995
      Jilin University, LLM

  • 1992

    • Education
       1992
      Qiqihar University, BA

Memberships

All China Lawyers Association

Law Society of Ontario

Representative Work

Peter holds strong connections with large enterprises, investment banks and governmental institutions in both China and abroad. Some of his most recent transactions include:

  • Share IPOs: issuer's counsel to JI Technologies (300309.sz); underwriter's counsel for China International Capital Corporation (CICC) in a transaction with Yi Tong Shi Ji (300310.sz)
  • Corporate M&A: purchaser's counsel in transactions for Huawei Technologies, CITICPE, New Horizon Capital, Ping An Venture Capital, and NARI Group (a subsidiary of State Grid)
  • H shares: underwriter's counsel for Morgan Stanley, CICC, UBS and others in a 2011 CCB follow-on offering
  • Red-chip listings: underwriter's counsel for CICC in a transaction with China Resource Pharmaceutical
  • Out-bound investments: investor's counsel for Tebian Electric Apparatus Stock Co. (600089.sh)
  • Bond issues: issuer's counsel for Yahgee Modular House Co. (002314.sz)
  • Commercial notes: issuer's counsel for Guangzhou Port Group and Zhan Jiang Port Group
  • Foreign investments: counsel for China Nuclear Power Engineering (CNPEC, subsidiary of CPNPC) in joint venture with Areva
  • Collective asset management funds: issuer's counsel for Essence Securities

Client work

Client work
13 September 2021 Providence Therapeutics and Everest Medicines enter into comprehensive agreements to advance mRNA vaccines and therapies in Asia emerging markets
Client work
25 August 2020 Zijin Mining completes acquisition of Guyana Goldfields